恒瑞医药(01276.HK)9月4日首次回购A股股份27万股

Group 1 - The company announced its first share buyback of 270,000 A-shares through centralized bidding on September 4, 2025 [1] - The repurchased shares account for 0.004% of the company's total share capital [1] - The highest transaction price was 67.97 CNY per share, while the lowest was 67.75 CNY per share, with a total payment of 18,313,920 CNY (excluding transaction fees) [1] Group 2 - The buyback complies with relevant laws and regulations as well as the company's established share repurchase plan [1]